Untangling the Impact of Plastics on Pharmaceuticals

EKG Life Science Solutions, LLC Announces Acquisition of State of the Art Instrumentation

EKG Life Science Solutions Announces Acquisition of State of the Art Instrumentation Ion Trap LC/MS, GC with FID and TCD, and FT-IR

St. Louis, MO— 11/26/14 — Today, EKG Life Science Solutions announced the addition of a High Pressure Liquid Chromatograph with Ion Trap Mass Spectrometry Detection (LC/MS), a Gas Chromatograph with Flame Ionization Detection (FID) and Total Conductivity Detection (TCD), and a Fourier Transform Infrared (FT-IR) Spectroscopy System, enabling additional analytical service offerings under cGMP.

“The addition of the new instrumentation will allow EKG Labs to offer more services under cGMP to the medical device and pharmaceutical development industries. We are extremely excited to bring these items online and are committed to the continual investment in resources which allow us to partner with our clients to best meet their regulatory requirements with sound science,” said Dr. Allen Kesselring, Chief Science Officer at EKG Life Science Solutions.

The new instrumentation is intended to help support programs such as extractable/leachable studies, impurity identification, residual solvents analysis, reference standard characterization, and other customized analytical services.

About EKG Life Science Solutions, LLC
Founded in 2013, EKG Life Science Solutions is quickly becoming the leader in contract analytical services to the pharmaceutical and medical device industries. The company offers a wide range of services designed to provide innovative analytical solutions to their partners in the pharmaceutical and medical device development communities.

For more information, press only:

Katie Grayson
810.354.5229
kgrayson@ekglabs.com

For more information on EKG Labs:
www.ekglabs.com